Provision of treatment for multiple sclerosis (vol 353, pg 1710, 1999)

被引：0

|

作者：

Compston, A

机构：

来源：

LANCET | 1999年 / 354卷 / 9177期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：518 / 518

页数：1

相关论文

共 50 条

[1] Mitoxantrone in the treatment of severe multiple sclerosis (vol 70, pg 723, 1999)
Cursiefen, S
Flachenecker, P
Rieckmann, P
Toyka, KV
NERVENARZT, 1999, 70 (12): : 1051 - 1051
[2] Intravenous immunoglobulin treatment in multiple sclerosis (vol 52, pg 214, 1999)
Elizur, A
NEUROLOGY, 1999, 52 (09) : 1952 - 1952
[3] Neuropsychologic status in multiple sclerosis after treatment with glatiramer (vol 56, pg 319, 1999)
Weinstein, A
Schwid, SR
Schiffer, RB
McDermott, MP
Giang, DW
Goodman, AD
ARCHIVES OF NEUROLOGY, 2004, 61 (08) : 1284 - 1284
[4] 'German Nihilism' (vol 26, pg 353, Spring 1999)
Strauss, L
INTERPRETATION-A JOURNAL OF POLITICAL PHILOSOPHY, 2000, 28 (01): : 33 - 34
[5] New antithrombotic agents (vol 353, pg 1431, 1999)
Hirsh, J
Weitz, JI
LANCET, 1999, 353 (9166): : 1804 - 1804
[6] Provision of treatment for multiple sclerosis
Compston, A
LANCET, 1999, 353 (9165): : 1710 - 1711
[7] Patients' ability to recall risk associated with treatment options (vol 353, pg 645, 1999)
Lloyd, AJ
LANCET, 1999, 353 (9170): : 2164 - 2164
[8] What level of care for the neurofibromatoses? (vol 353, pg 1114, 1999)
Huson, S
LANCET, 1999, 353 (9161): : 1366 - 1366
[9] A pill a day, or two, for hepatitis B? (vol 353, pg 32, 1999)
Dusheiko, G
LANCET, 1999, 353 (9165): : 1714 - 1714
[10] Homocysteine in cerebral macroangiography and microangiopathy. (vol 353, pg 1586, 1999)
Fassbender, K
Mielke, O
Bertsch, T
Nafe, B
Froschen, S
Hennerici, M
LANCET, 2006, 367 (9519): : 1318 - 1318

← 1 2 3 4 5 →